Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer (NEST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2013 by Asan Medical Center
Sponsor:
Collaborator:
Korean Breast Cancer Study Group
Information provided by (Responsible Party):
Sei-Hyun Ahn, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01622361
First received: June 13, 2012
Last updated: September 26, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)